Skip to main content
. 2015 Dec 20;21:3961–3977. doi: 10.12659/MSM.895005

Table 4.

Subgroup analysis patients without UGIB at Child-Pugh class B and C.

Variables Total Pts (n=56) Moderate-large varices Pts (n=32) No-mild varices Pts (n=24) P value With varices Pts (n=37) Without varices Pts (n=19) P value
Sex (male/female) 36/20 19/13 17/7 0.376 21/16 15/4 0.101
Age (years) 55.63±10.55 56.55±10.45 54.41±10.78 0.457 54.74±12.02 57.36±6.79 0.383
Etiology of liver diseases, n (%) 0.355 0.617
 Hepatitis B virus 6 (10.7) 5 (15.6) 1 (4.2) 5 (13.5) 1 (5.3)
 Hepatitis C virus 5 (8.9) 3 (9.4) 2 (8.3) 4 (10.8) 1 (5.3)
 Hepatitis B virus + Hepatitis C virus 1 (1.8) 1 (3.1) 0 (0) 1 (2.7) 0 (0)
 Alcohol 19 (33.9) 9 (28.1) 10 (41.7) 10 (27.0) 9 (47.4)
 Hepatitis B virus + Alcohol 5 (8.9) 3 (9.4) 2 (8.3) 3 (8.1) 2 (10.5)
 Unknown 13 (23.2) 5 (15.6) 8 (33.3) 8 (21.6) 5 (26.3)
 Others 7 (12.5) 6 (18.8) 1 (4.2) 6 (16.2) 1 (5.3)
Ascites, n (%) 0.763 0.436
 No 11 (19.6) 6 (18.8) 5 (20.8) 6 (16.2) 5 (26.3)
 Mild 14 (25.0) 7 (21.9) 7 (29.2) 11 (29.7) 3 (15.8)
 Moderate to severe 31 (55.4) 19 (59.4) 12 (50.0) 20 (54.1) 11 (57.9)
Hepatic encephalopathy, n (%) 0.382 0.47
 No 55 (98.2) 31 (96.9) 24 (100) 36 (97.3) 19 (100)
 Grade I–II 1 (1.8) 1 (3.1) 0 (0) 1 (2.7) 0 (0)
 Grade III–IV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Varices, n (%) NA NA
 No 19 (33.9) 0 (0) 19 (79.2) 0 (0) 19 (100)
 Mild 5 (8.9) 0 (0) 5 (20.8) 5 (13.5) 0 (0)
 Moderate 12 (21.4) 12 (37.5) 0 (0) 12 (32.4) 0 (0)
 Severe 20 (35.7) 20 (62.5) 0 (0) 20 (54.1) 0 (0)
Laboratory tests
 RBC 3.47±0.70 3.38±0.68 3.57±0.72 0.321 3.41±0.66 3.57±0.76 0.418
 Hb 110.79±25.26 108.16±25.74 114.29±24.72 0.373 108.51±25.02 115.21±25.83 0.352
 WBC 4.76±2.84 4.48±3.08 5.13±2.50 0.398 4.36±2.97 5.53±2.48 0.147
 PLT 94.46±68.76 77.69±57.08 116.83±77.46 0.034 77.00±56.17 128.47±79.29 0.007
 TBIL 43.86±49.60 39.50±25.78 49.66±70.19 0.453 38.18±25.02 54.90±77.92 0.236
 DBIL 26.93±40.35 22.41±21.48 32.97±56.61 0.337 21.58±20.53 37.37±62.91 0.168
 IBIL 16.93±14.50 17.10±10.37 16.71±15.11 0.911 16.61±10.16 17.56±16.44 0.789
 ALB 31.57±5.42 30.24±4.23 33.34±6.35 0.033 30.50±4.86 33.65±5.96 0.038
 ALT 65.91±170.15 45.84±45.67 92.67±255.18 0.313 43.86±42.84 108.84±286.09 0.178
 AST 91.02±136.48 91.59±134.20 90.25±142.36 0.971 86.00±125.87 100.79±158.35 0.705
 ALP 142.19±98.51 138.69±104.10 146.84±92.52 0.762 137.44±105.29 151.43±85.69 0.619
 GGT 185.80±260.43 185.16±299.19 186.67±203.82 0.983 172.89±282.97 210.95±214.69 0.609
 BUN 6.18±4.14 5.50±2.78 7.08±5.39 0.161 5.46±2.62 7.57±5.96 0.072
 Cr 69.96±60.95 61.72±36.15 80.93±83.08 0.247 59.35±34.22 90.62±91.26 0.069
 PT 16.12±2.74 16.27±2.36 15.92±3.22 0.638 16.31±2.51 15.75±3.18 0.479
 APTT 44.72±7.15 45.28±6.57 43.98±7.94 0.506 45.85±7.26 42.51±6.55 0.097
 INR 1.30±0.29 1.32±0.27 1.28±0.33 0.651 1.32±0.28 1.27±0.33 0.489
Child-Pugh score 8.18±1.36 8.34±1.31 7.96±1.43 0.299 8.32±1.42 7.89±1.24 0.268
MELD score 7.27±6.49 7.07±5.15 7.54±8.06 0.79 6.57±5.32 8.63±8.32 0.265
APRI score 4.05±6.77 4.86±8.48 2.97±3.28 0.305 4.57±7.93 3.04±3.57 0.429
AAR score 1.90±1.05 2.03±1.08 1.73±1.01 0.286 1.97±1.04 1.77±1.09 0.502
FIB-4 score 10.44±10.40 12.70±12.16 7.42±6.53 0.06 11.97±11.60 7.46±6.87 0.126
FI score −24.51±5.65 −23.02±4.23 −26.51±6.71 0.021 −23.27±4.84 −26.94±6.43 0.02
King score 114.47±242.56 143.47±310.32 75.81±90.42 0.306 132.53±290.18 79.31±96.92 0.442

AAR – AST to ALT ratio; ALB – albumin; ALP – alkaline phosphatase; ALT – alanine aminotransferase; APRI – AST to platelets ratio index; APTT – activated partial thromboplastin time; AST – aspartate aminotransferase; AUC – area under curve; BUN – blood urea nitrogen; Cr – creatinine; DBIL – direct bilirubin; FI – fibrosis index; FIB-4 – fibrosis 4 index; GGT – gamma-glutamyl transpeptidase; Hb – hemoglobin; IBIL – indirect bilirubin; INR – international normalized ratio; MELD – model for end-stage liver disease; NA – not available; PLT – platelet; PT – prothrombin time; Pts – patients; RBC – red blood cell; TBIL – total bilirubin; UGIB – upper gastrointestinal bleeding; WBC – white blood cell.